Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tomy Salloum"'
Autor:
Gilles Montalescot, Alban Redheuil, Flavien Vincent, Steffen Desch, Mauro De Benedictis, Hélène Eltchaninoff, Dietmar Trenk, Jean-Michel Serfaty, Etienne Charpentier, Khaoula Bouazizi, Mikael Prigent, Paul Guedeney, Tomy Salloum, Sergio Berti, Angel Cequier, Thierry Lefèvre, Pascal Leprince, Johanne Silvain, Eric Van Belle, Franz-Josef Neumann, Jean-Jacques Portal, Eric Vicaut, Jean-Philippe Collet
Publikováno v:
JACC: Cardiovascular Interventions. 15:1794-1804
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d48eb0441721ece39a8edba3eb0e5155
https://doi.org/10.1016/j.jcin.2022.07.014
https://doi.org/10.1016/j.jcin.2022.07.014
Autor:
David Sulman, Michel Zeitouni, Johanne Silvain, Mathieu Kerneis, Paul Guedeney, Olivier Barthélémy, Delphine Brugier, Pierre Sabouret, Benoit Lattuca, Emilie Mertens, Julianne Posson, Niki Procopi, Tomy Salloum, Jean-Philippe Collet, Gilles Montalescot
Publikováno v:
European Heart Journal - Cardiovascular Pharmacotherapy. 8:633-643
Aims The European Society of Cardiology (ESC) has released three consecutive guidelines within 5 years addressing cardiovascular prevention, risk scores, and cholesterol treatment. This study aims to evaluate whether the 2021 ESC guidelines improved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db94c40014c380dcd80ad146a9326c1
https://doi.org/10.1093/ehjcvp/pvac021
https://doi.org/10.1093/ehjcvp/pvac021
Autor:
Gilles, Montalescot, Alban, Redheuil, Flavien, Vincent, Steffen, Desch, Mauro, De Benedictis, Hélène, Eltchaninoff, Dietmar, Trenk, Jean-Michel, Serfaty, Etienne, Charpentier, Khaoula, Bouazizi, Mikael, Prigent, Paul, Guedeney, Tomy, Salloum, Sergio, Berti, Angel, Cequier, Thierry, Lefèvre, Pascal, Leprince, Johanne, Silvain, Eric, Van Belle, Franz-Josef, Neumann, Jean-Jacques, Portal, Eric, Vicaut, Jean-Philippe, Collet
Publikováno v:
JACC. Cardiovascular interventions. 15(18)
Subclinical obstructive valve thrombosis after transcatheter aortic valve replacement (TAVR) is of uncertain frequency and clinical impact.The aim of this study was to determine the effects of apixaban vs standard of care on post-TAVR valve thrombosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ee21c3f6aeada1f7d540da75b466eb5
https://pubmed.ncbi.nlm.nih.gov/36057537
https://pubmed.ncbi.nlm.nih.gov/36057537